X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (110) 110
humans (87) 87
cardiac & cardiovascular systems (60) 60
male (58) 58
female (55) 55
life sciences (42) 42
middle aged (40) 40
aged (36) 36
abridged index medicus (33) 33
animals (30) 30
risk factors (30) 30
cardiovascular (28) 28
atrial fibrillation (27) 27
stroke (24) 24
care and treatment (23) 23
human health and pathology (20) 20
treatment outcome (20) 20
internal medicine (19) 19
mortality (19) 19
percutaneous coronary intervention (19) 19
retrospective studies (19) 19
ischemia (17) 17
myocardial infarction (17) 17
analysis (16) 16
cardiology (16) 16
heart (16) 16
adult (15) 15
cardioprotection (14) 14
heart attack (14) 14
pharmacology & pharmacy (14) 14
research (14) 14
time factors (14) 14
atrial fibrillation - complications (13) 13
cardiology and cardiovascular medicine (13) 13
follow-up studies (13) 13
mice (13) 13
reperfusion injury (13) 13
surgery (13) 13
acute myocardial-infarction (12) 12
atrial fibrillation - drug therapy (12) 12
heart attacks (12) 12
management (12) 12
patients (12) 12
peripheral vascular disease (12) 12
risk (12) 12
anticoagulants (11) 11
anticoagulants - therapeutic use (11) 11
france - epidemiology (11) 11
myocardial infarction - therapy (11) 11
reperfusion (11) 11
risk assessment (11) 11
transplantation (11) 11
aged, 80 and over (10) 10
heart failure (10) 10
inflammation (10) 10
monoclonal antibodies (10) 10
prognosis (10) 10
prospective studies (10) 10
stents (10) 10
stroke - etiology (10) 10
stroke - prevention & control (10) 10
clinical trials (9) 9
dosage and administration (9) 9
myocardial-infarction (9) 9
rats (9) 9
respiratory system (9) 9
warfarin (9) 9
cardiac arrhythmia (8) 8
cardiology and cardiovascular system (8) 8
cardiovascular disease (8) 8
disease models, animal (8) 8
echocardiography (8) 8
health aspects (8) 8
medicine & public health (8) 8
mitochondrial permeability transition (8) 8
oral anticoagulation (8) 8
therapy (8) 8
usage (8) 8
administration, oral (7) 7
cardiomyocytes (7) 7
coronary vessels (7) 7
diagnosis (7) 7
european-society (7) 7
expression (7) 7
impact (7) 7
magnetic resonance imaging (7) 7
medicine, general & internal (7) 7
metaanalysis (7) 7
mice, inbred c57bl (7) 7
myocardial reperfusion injury - prevention & control (7) 7
pharmacology (7) 7
prevention (7) 7
risk-factors (7) 7
acute coronary syndromes (6) 6
atrial fibrillation - mortality (6) 6
bioengineering (6) 6
biomarkers - blood (6) 6
biopharmaceuticals (6) 6
cardiac patients (6) 6
cardiogenic shock (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 1021 - 1021
  Background: After a myocardial infarction (MI), dual antiplatelet therapy (DAPT) has proven beneficial to reduce the risk of thrombotic events recurrences... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | Care and treatment | Usage | Cardiac patients | Heart attack | Health risk assessment | Patients | Heart attacks
Journal Article
Journal Article
THERAPIE, ISSN 0040-5957, 09/2017, Volume 72, Issue 4, pp. 411 - 413
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 05/2018, Volume 136, Issue 5, pp. 557 - 566
IMPORTANCE: The systemic safety of intravitreal anti–vascular endothelial growth factor (anti-VEGF) medications is still a matter of debate. OBJECTIVE: This... 
TRIAMCINOLONE ACETONIDE | MYOCARDIAL-INFARCTION | BEVACIZUMAB | SAFETY | RANIBIZUMAB LUCENTIS | SECONDARY | OPHTHALMOLOGY | DIABETIC MACULAR EDEMA | RETINAL VEIN OCCLUSION | AFLIBERCEPT | DEGENERATION
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 08/2017, Volume 83, Issue 8, pp. 1773 - 1781
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 12/2016, Volume 116, Issue 6, pp. 1150 - 1158
The safety of dabigatran versus adjusted-dose vitamin K antagonist (VKA) treatment is the subject of debate. We evaluated the risk of myocardial infarction... 
Myocardial infarction | Dabigatran | Vitamin K antagonist | Atrial fibrillation | ISCHEMIC EVENTS | SAFETY | CORONARY | myocardial infarction | REAL-WORLD PATIENTS | NATIONWIDE COHORT | vitamin K antagonist | RANDOMIZED-CONTROLLED-TRIALS | WARFARIN | ORAL ANTICOAGULANTS | CLINICAL-TRIALS | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | ASSOCIATION
Journal Article
Therapie, ISSN 0040-5957, 09/2017, Volume 72, Issue 4, pp. 411 - 413
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 05/2018, Volume 136, Issue 5, p. 557
Importance The systemic safety of intravitreal anti–vascular endothelial growth factor (anti-VEGF) medications is still a matter of debate. Objective This... 
Occlusion | Edema | Diabetes mellitus | Clinical trials | Retina | Hemorrhage | Patients | Risk factors | Meta-analysis | Bevacizumab | Studies | Macular degeneration | Degeneration | Prescriptions | Vascular endothelial growth factor
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 11, pp. 1021 - 1031
Patients with acute STEMI undergoing PCI were assigned to cyclosporine or placebo. No significant between-group difference was seen in the rate of death,... 
HEART | MEDICINE, GENERAL & INTERNAL | MITOCHONDRIAL PERMEABILITY TRANSITION | PERCUTANEOUS CORONARY INTERVENTION | INJECTION | REPERFUSION INJURY | SIZE | PORE | ISCHEMIA | CARDIOPROTECTION | ASPIRATION | Enzyme Inhibitors - adverse effects | Injections, Intravenous | Double-Blind Method | Humans | Middle Aged | Mortality | Kaplan-Meier Estimate | Male | Combined Modality Therapy | Enzyme Inhibitors - administration & dosage | Cyclophilins - antagonists & inhibitors | Myocardial Infarction - therapy | Myocardial Infarction - drug therapy | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | Electrocardiography | Female | Aged | Heart Failure - epidemiology | Ventricular Remodeling - drug effects | Percutaneous Coronary Intervention | Care and treatment | Usage | Angiography | Heart enlargement | Dosage and administration | Cyclosporine | Heart attack | Occlusion | Myocardial infarction | Heart | Cerebral infarction | Heart attacks | Intravenous administration | Cyclosporins | Angioplasty | Body weight | Coronary artery | Clinical trials | Angina | Patients | Clinical outcomes | Reperfusion | Ventricle | Drug therapy | Heart diseases | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Bioengineering | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 5, pp. 473 - 481
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 12/2016, Volume 129, Issue 12, pp. 1278 - 1287
Journal Article
Journal Article
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 02/2019, Volume 73, Issue 7, pp. 755 - 757
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.